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Abstract
Background: Symptoms of depression can be recurrent or limited to one episode. This study discusses the
prospective association between psychological health, measured as change in depression symptoms, and the risk
of diabetes mellitus in Australian women.
Methods: Data obtained from the Mater-University of Queensland Study of Pregnancy. Depression was measured
using the Delusions-Symptoms: States Inventory. To examine possible transitions over time, depression was
grouped into four categories and assessed at different phases over the 21-year period. Multiple logistic regression
models and sensitivity analysis to assess the robustness of our analytical strategy were performed.
Results: Three hundred and one women reported diabetes 21 years after the index pregnancy. Almost one-third
of the women who reported depression symptoms continued to report these at a subsequent follow-up (FU)
phase. About 1 in 20 women who had not reported depression symptoms at the 5-year FU did so at the
subsequent 14-year FU. In prospective analyses, we did not find a significant association between diabetes and
negative change (not depressed to depressed, at subsequent phase); however, for women with positive history of
symptoms of depression and women with persistent symptoms, there was a 1.97-fold (95% confidence interval
[CI]: 1.14–3.40) to 2.23-fold (95% CI: 1.09–4.57) greater risk of diabetes.
Conclusions: Our study suggests that an increased risk of diabetes is significantly associated with persistent
depression symptoms. It highlights the importance of recognizing depression symptoms in terms of women’s
psychological wellbeing and thus provides a basis for targeting those most at risk.
Introduction
D iabetes mellitus may be described as a chronic pro-gressive disorder, and is often coupled with multiple mor-
bidities that include physical as well as psychological disorders.1
Obesity and lack of physical exercise are well-known, modifi-
able risk factors of diabetes,2 while depression is a common,
comorbid, and modifiable condition3,4 and is the most widely
studied psychological condition associated with diabetes.5–7 The
prevalence of depression in people with diabetes is considerably
higher than the normal population and ranges between 10% and
30%.5,8,9 People with diabetes are at higher risk of developing
depression,3,5 and vice versa.6,7 Symptoms of depression are
recurrent, chronic, or limited to one episode; therefore depres-
sion often remains unrecognized and thus, untreated.10
Diabetes is a leading cause of mortality worldwide and re-
sulted in 1.0 million (1.9%) deaths in 2000, which increased to
1.4 million (2.6%) deaths in 2011.11 Depressive disorder is a
major contributor to the burden of disease.12 In Australia, both
diabetes and depression contribute significantly to the burden
of disease, with depression the leading contributor among
women.13 Stressful events are a well-documented cause of
depression and women usually experience more potentially
stressful life events (for example, pregnancy),14 particularly
prior to the onset of diabetes. Women with diabetes and co-
morbid depression reported experiencing greater disease bur-
den and restrictions in their social interactions as well as more
physical complaints,15 poor diabetes self-care, and poor gly-
cemic control.16 However Rotella et al. suggested that clinical
features have a much greater impact on attainment of thera-
peutic goals than psychopathology.17
Several longitudinal studies from developed countries sug-
gest that the association between depression and diabetes is
reciprocal or bidirectional.3,18,19 The bidirectional association
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between diabetes and depression was first documented by
Golden et al., who described the relationship as ‘‘modest’’ and
‘‘partially explained by lifestyles,’’19 and Eaton and colleagues
were the first to report the results of an epidemiological study
that confirmed the relationship between depression and diabetes
in 1996.20 Multiple meta-analyses have suggested an associa-
tion between depression and diabetes as bidirectional.6,7,21,22
However, among psychiatric disorders or symptoms, not only
depression or anxiety are independently associatedwith diabetes
onset, impulse control disorders such as eating disorders are also
important.23
A consistent association between diabetes and psychiatric
disorders is commonly found in the literature;3,6,7 however,
change in depression symptoms (positive, negative, persistent
symptoms) and the risk of developing diabetes have not been
studied formally, particularly when symptoms of depression
can be recurrent or limited to one episode. Therefore. this study
examines the relationship between psychological health, mea-
sured as change in depression symptoms and the risk of dia-
betes for a large cohort of women who were followed up at
intervals over a 21-year period postpartum, and takes into ac-
count a range of potential confounding factors. We performed
sensitivity analysis to assess the robustness of our analytical
strategy. Finally, we also examined the cross-sectional asso-
ciation between depression and diabetes.
Materials and Methods
Participants
We examined the association between depression symp-
toms and subsequent reporting of diabetes mellitus 21 years
postpartum in a sample of women who were part of an
Australian pregnancy and birth cohort. The Mater-University
of Queensland Study of Pregnancy (MUSP) is a multidisci-
plinary study that represents Australia’s largest longitudinal
study spanning a large part of a woman’s reproductive life
from pre-birth for 21 years postpartum. The longitudinal
study began in 1978–1979 with a number of pilot studies, and
full data collection commenced in January, 1981. Women
recruited into the study gave birth at the Mater Misericordiae
Mothers’ Hospital, which is one of two major obstetric units
in Brisbane, Australia.24,25 The original study was approved
by the Human Subjects Research Ethics Committee of the
University of Queensland and was conducted according to
the Declaration of Helsinki.
Data were collected prospectively across the reproductive
life course of a large group of women. Originally 7861 women
were enrolled (8556 pregnancies), and of these women, 6753
constitute the ‘‘MUSP mothers’’ cohort. Women enrolled in
the cohort had to deliver at least one live babywho neither died
nor was adopted before leaving the hospital and have (initial)
data from the first clinic visit (FCV), at approximately 18
weeks’ gestation, and shortly after the birth. These women
were reinterviewed 3 to 5 days after delivery, and data from
their medical records were also collected. Additional inter-
views and follow-ups were conducted when the children were
6 months, 5 years, 14 years, and 21 years of age. At the start of
the MUSP study, women who were cared for at this hospital
were not screened routinely for gestational diabetes mellitus.
Women who had been diagnosed with diabetes mellitus before
the index pregnancy or who developed gestational diabetes
mellitus, or type 1 diabetesmellitus, that was diagnosed during
the index pregnancy (n= 46), were excluded from analysis.
After excluding women who did not provide any information
regarding the presence of diabetes mellitus at the 21-year
follow-up, 3663 women provided information regarding their
own physical health and diabetes mellitus.
Measurement of diabetes mellitus
The outcome in our analyses was information regarding
self-reported diabetes mellitus in the 21 years after the index
pregnancy; data were collected using a self-administered
questionnaire. Women were asked, ‘‘Have you EVER been
told by a doctor that you have diabetes mellitus (high blood
sugar)?’’ Women with preexisting or gestational diabetes
mellitus at the time of the index pregnancy were excluded
from this study, and a positive response to this question in-
dicated that the woman had incident diabetes mellitus some
time during the 21 years after the index pregnancy.26
Measurement of depression symptoms
The exposure was depression symptoms measured at 5
years and 14 years after delivery; symptoms were assessed
using the seven-item depression subscale from the Delusion
Symptoms States Inventory: State of Anxiety and Depression
(DSSI/sAD).27 This measure was developed to detect the
signs and symptoms of psychopathology that limit a person’s
capacity to function and maintain relationships. The measure
has high internal validity,27,28 correlates well, and shares
items with other measures of depression and anxiety, such as
the Edinburgh Postnatal Depression Scale and the Hospital
Anxiety and Depression Scale.29 In MUSP, the Cronbach’s
alphas for the scale (DSSI/sAD) ranged from 0.79 to 0.88,
measured at 14-year follow-up.30 In the present study, the
seven items, each with 5-point response options (never,
rarely, some of the time, most of the time, or all the time),
were summed [score range: 10 (all the time) to 50 (never)];
the lower the score, the more depressed the person. Women
who reported four or more symptoms were considered to be
depressed.27
Defining changes in depression symptoms:
psychological health
We examined psychological health by estimating the ob-
served proportion of women who reported a change in de-
pression symptoms between subsequent phases of the study.
In the present study, diabetes was the dependent variable at
21 years, and changes in depression symptoms (i.e., transi-
tions) from the previous two phases (at 5- and 14-year follow-
ups), was the main predictor. Potential confounding factors
for each of the transition models (changes in depression
symptoms) were included from the most recent or relevant
previous phase. MUSP is a prospective study with unequal
time intervals between data collection phases, andmost of the
variables are time dependent; therefore, the number of wo-
men making transitions (that is, experiencing changes in
depression symptoms) for exposure at each of the unequal
time intervals was estimated in the following manner:30
possible transitions that could occur during the period from
the 5-year follow-up (FU) (origin state) to the 14-year FU
(destination state) were classified into four categories, based
on 1 standard deviation above the mean cutoff. The
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categories are (1) no depression, (2) women reporting de-
pression at 5-year but not at 14-year FU (positive history of
depression), (3) women reporting depression at 14-year FU
but not at 5-year FU (negative change), and (4) women with
persistent depression symptoms.
Given the length of time between the follow-ups, it is
likely that some women may have experienced more than
one episode of depression during that time. Two phases—
post-delivery (3–5 days after delivery) and 6-month follow-
up—were not included, as pregnancy or intervals after
delivery may be sensitive periods with regard to depres-
sion symptoms and could confound the associations under
investigation.
Sensitivity analysis
There were two phases that were not included in the main
analysis: post-delivery (3–5 days after delivery) and 6-month
follow-up. However, we used these phases to assess the ro-
bustness of our analytical strategy: the sensitivity analysis
was performed using the same possible transitions during 3–5
days FU (origin state) to the 6-month FU (destination state).
They were classified into the same four categories used in the
main analysis.
Adjustment for potential confounding
The potential confounders and risk factors were identified
on the basis of their association with outcomes and on the basis
of a priori knowledge.6,7 We determined six variables neces-
sary to control for confounding: age, marital status to 5-year
FU, family annual incomes to 5-year FU, education, use of
psychotropic drugs and body mass index (BMI). Age at first
clinic visit, both as a categorical and continuous variable, was
included. At each phase during the study, the woman was
asked her current marital status; that is, whether she was
married, living together, separated/ divorced, or single. A
change in marital status to 5 years post-delivery was included,
and this measure was categorized into nil partner change, one
change, or two plus changes. In the data collection stages of the
study, namely at 5, 14, and 21 years, women were asked to
select, from a 7-point scale, the (Australian) dollar range that
best represented their total family annual income. In the cur-
rent study, changes in family annual income to 5 years FU
were categorized into consistent poverty, mid income, and
high income. Maternal education at the first antenatal visit was
recorded as one of three categories: did not complete sec-
ondary schooling, completed secondary schooling, and com-
pleted further or higher education. The information about
psychotropic drugs was categorized as yes and no.
Participants’ height and weight at first antenatal visit and
an estimate of prepregnancy weight were obtained at the start
of the study, from either obstetric records or questionnaires.
Participants’ estimates of prepregnancy weight and measured
weight on the first antenatal visit correlated highly (Pearson’s
correlation coefficient, 0.95).22 In the present study, BMI was
categorized into normal, 10% low, and 10% high.
Statistical analysis
The data were analyzed using the Statistical Package
for Social Sciences (SPSS) version 20 and Stata IC ver-
sion 12 (StataCorp LP), with a significance level of £ 0.05.
Descriptive statistics were used to calculate percentages, fre-
quencies, means, and standard deviations. The Student t-test
and chi-squared tests were used to compare the characteristics
of those women who did and did not provide information about
diabetes at 21-year evaluation, or who were lost to follow-up
and therefore excluded from the analysis. Multiple logistic
regression models were then used to further assess the associ-
ation between the characteristics, depression symptoms, and
diabetes, measured at FCV (at the start of the study), with those
lost to follow-up or with incomplete data.
Logistic regression was used to assess the relationship
between depression symptoms and self-reported diabetes
mellitus. Multiple logistic regression was then used to further
assess the relationship between depression symptoms and
subsequent self-report of diabetes mellitus, after adjustment
for other potential confounding variables. The same method
was used for longitudinal and cross-sectional data.
We present a series of models that were adjusted for the
potential confounders so that readers can see the effect of
factors that we considered might confound this association.
Multiple imputations were carried out to adjust for missing
data.31 Combining the results of the analyses of the complete
datasets using Rubin’s rules was performed in Stata IC ver-
sion 12.0. The relationship between ‘‘missingness’’ (yes
versus no) and the predictor variables was assessed using
logistic regression.
Investigation of missing data
The distribution of missingness of study covariates by
outcome (diabetes at 21-year follow-up is shown in Table 1.
Of the 6753 women who were eligible for this study, 3663
women (54.2%) completed the 21-year follow-up and pro-
vided information regarding the diagnosis of diabetes mel-
litus (excluding type 1 and gestational diabetes). The same
subset (3663) was used to impute for the missing values on
study covariates. The proportion of missing data ranged from
0% to 20% for all variables. For the main predictor, ‘‘changes
in depression symptoms,’’ 22% of data were missing, and
therefore, data were imputed for all covariates except age,
where the amount of missing data was zero. It is generally
recommended to impute more than the percentage of missing
data,32 and therefore we imputed missing data based on the
percentage of missing data on covariates. An imputation
model was devised using the recommendations of Van
Buuren et al.33 The model included all the predictor variables
excluding the outcome i.e. presence or absence of diabetes
(yes/no). The data on covariates were assumed to be ‘‘miss-
ing at random,’’ which means that the probability of the data
being missing may depend on observed values.34
For each of the completed datasets, a logistic regression
was performed (inclusion of all predictor variables without
outcome), from which the estimate of interest and its esti-
mated variance were obtained. The results from the logistic
regression modelling of the different datasets were combined
using the rules proposed by Rubin to produce a multiple
imputation estimate.35 The estimate obtained for multiple
imputations is simply the average of the different estimates.
Results
A total of 301 (8.2%) of the participating women reported
diabetes at 21-year FU. The proportion of women with four or
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more symptoms was 13.69% at post-delivery (3–5 days after
delivery) and 13.35% at the 14-year FU. In our descriptive
analysis, of the women with persistent depression symptoms,
almost 17% reported diabetes compared with about 8% of
women persistently not depressed. About 13% and 8% of
women with positive and negative change, respectively, re-
ported diabetes at 21-year follow-up (Fig. 1).
The proportion of women reporting transitions or changes
(depression symptoms) between consecutive phases (5-year
and 14-year FU) is presented in Table 2. About one-third
(33.2%) of the women who reported depression symptoms (at
5-year FU) continued to report these at the subsequent 14-year
FU phase. About 1 in 20 women (5.7%) who had not reported
depression symptoms at the 5-year FU did so at the subsequent
14-year FU. However, transitions can only inform us of the
proportion of women changing from one state to another,
whereas multivariate analysis can provide further insight into
the independent developmental processes associated with
these transitions.30 Results from multivariate analyses for
women with imputed data on all variables are presented in
Table 3, using four models. The first of these models, all of
which used longitudinal data, presents unadjusted estimates,
while age was included in Model 2. In Model 3, socio-
demographic characteristics were included in the analysis, and
finally, in the fourth model (4) the estimates were further ad-
justed for use of psychotrophic drugs and BMI. In the unad-
justed Model 1, women with persistent symptoms (depression
symptoms at both 5-year and 14-year FUs) had a 2.45-fold
greater risk of diabetes (95% confidence interval [95%
CI]: 1.23–4.92). The effect size of negative change (from no
Table 1. Comparison Between Lost to Follow-Up and Information Collected for Diabetes
at 21-Year Follow-Up by Sociodemographic and Clinical Factors
Factors Number
Women who
provided diabetes
data at 21-year
FU (n = 3686)
Women who
were missing
at 21-year FU
(n = 3067)
Adjusted
OR (95% CI)a
Chi-squared
p-value
Mothers’ age at entry to study (years) - 25.49– 5.02 24.43 – 5.27 - -
Changes in depression symptoms
Persistently not depressed 3554 2710 (67.1) 844 (20.9) 1.00 > 0.05
No depression to depression 233 165 (4.1) 68 (1.7) 0.81 (0.57–1.14)
Depression to no depression 161 119 (2.9) 42 (1.1) 1.08 (0.69–1.69)
Persistent depression symptoms 85 59 (1.5) 26 (0.6) 0.66 (0.38–1.14)
Age groups
13–19 1146 482 (13.1) 664 (21.6) 1.00
20–34 5307 3036 (82.4) 2271 (74.1) 1.17 (0.90–1.52)
‡ 35 300 168 (4.6) 132 (4.3) 1.05 (0.66–1.68) > 0.05
Changes in marital status to 5-year FU
Nil partner change 3859 2695 (73.1) 1164 (37.9) 1.00
One change 480 292 (7.9) 188 (6.1) 0.98 (0.72–1.33)
Two plus 389 240 (6.5) 149 (4.9) 1.06 (0.76–1.47) > 0.05
Changes in family annual income
Consistent poverty 225 131 (3.6) 94 (3.1) 1.00
Mid income 3424 2385 (64.7) 1039 (33.9) 1.30 (0.87–1.93)
High income 476 369 (10.0) 107 (3.5) 1.60 (1.01–2.57) 0.001
Education level
Incomplete secondary education 1215 572 (15.5) 643 (21.0) 1.00
Complete secondary education 4294 2354 (63.9) 1940 (63.2) 1.23 (0.98–1.54)
Post-secondary education 1190 734 (19.9) 456 (14.9) 1.69 (1.27–2.26)* 0.001
Body mass index
Normal 5004 2843 (77.1) 2161 (70.5) 1.00
Low 10% 629 303 (8.2) 326 (10.6) 1.08 (0.81–1.44)
High 10% 599 322 (8.7) 277 (9.0) 0.96 (0.66–1.40) > 0.05
aAdjusted for all other variables in table.
bPredictive variable equals ‘‘diabetes at 21-year FU’’ not missing (coded as ‘‘0’’) vs missing (coded as ‘‘1’’).
CI, confidence interval; FU, follow-up; OR, odds ratio.
FIG. 1. Proportions of women reporting diabetes, by
change in depression symptoms.
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depression to depression) is comparable to a positive change
(from depression to no depression); however, only positive
change was significantly associated with diabetes (odds ratio
[OR] 1.91; 95% CI: 1.12–3.25).
In Model 2, experiencing depression symptoms at both the
5-year FU and 14-year FU was significantly associated with
diabetes at the 21-year FU (2.49;95% CI: 1.24–4.98), as well
as positive change (1.95; 95% CI: 1.15–3.32) (Table 3).
Models 3 and 4 were included to further adjust for the pos-
sible effects of sociodemographics, psychotropic drugs, and
BMI, and the associations identified remained consistent and
robust for persistent depression. In the fully adjusted model
(Model 4), women with positive change had a 1.97-fold risk
(95% CI: 1.14–3.40), while those with persistent symptoms
had a 2.23-fold risk (95% CI: 1.09–4.57) of subsequent dia-
betes at the 21-year FU.
In cross-sectional analysis, the unadjusted and age-
adjusted models produced significant associations between
depression symptoms and diabetes (both measured at 21-year
follow-up study) (Table 4). In the multivariate model, the
association became insignificant. It is interesting to note that
after multiple imputations, we observed that effect sizes were
reduced, but there was increased precision suggested by
narrow confidence intervals.
Sensitivity analysis
In order to examine the robustness of our findings and to
ensure that our findings are not spurious, we conducted a
sensitivity analysis using the same analytical strategy but
with depression symptoms measured at different time points.
Similar to the findings of our main analysis, women with
persistent depression symptoms (6.33; 95% CI: 2.50–16.00)
and women with positive change (1.82; 95% CI: 1.01–3.31)
were significantly associated with diabetes.
Discussion
This study examines the prospective association between
psychological health, measured as change in depression
symptoms, and the reporting of diabetes mellitus in Australian
women and found that almost one-third who reported de-
pression symptoms at 5-year FU continued to report these at
the subsequent 14-year FU phase. About 1 in 20 women who
had not reported depression symptoms at 5-year FU did so at
Table 2. Proportion (Percent) of Women Who
Experienced Change in Depression
Symptoms Between Phases
Symptom reported
at each phase Symptom at subsequent phase (%)
Post-delivery 6-month FU
No depression Depression n
No depression 97.0 3.0 3415
Depression 83.1 16.9 118
6-month FU 5-year FU
No depression Depression n
No depression 94.8 5.2 3064
Depression 78.9 21.1 109
5-year FU 14-year FU
No depression Depression n
No depression 94.3 5.7 2875
Depression 66.8 33.2 178
14-year FU 21-year FU
No depression Depression n
No depression 91.4 8.6 3090
Depression 62.8 37.2 250
Table 3. Unadjusted and Adjusted Odds Ratios (95% CI) of Reporting Diabetes at 21-Year
Follow-Up, by Changes in Depression Symptoms (Longitudinal Analysis)
Items No diabetes (referent) Diabetes mellitus
Persistently not depressed (referent) 1.00 1.00
Model 1 (unadjusted) n= 3663
No depression changes to depression 1.00 1.13 (0.84–1.51)
Depression changes to no depression 1.00 1.91 (1.12–3.25)*
Persistent depression symptoms 1.00 2.45 (1.23–4.92)*
Model 2a (age adjusted) n= 3663
No depression changes to depression 1.00 1.13 (0.85–1.51)
Depression changes to no depression 1.00 1.95 (1.15–3.32)*
Persistent depression symptoms 1.00 2.49 (1.24–4.98)*
Model 3b (adjusted) n= 3663
No depression changes to depression 1.00 1.11 (0.83–1.48)
Depression changes to no depression 1.00 1.91 (1.11–3.29)*
Persistent depression symptoms 1.00 2.41 (1.20–4.85)*
Model 4c (adjusted) n= 3663
No depression changes to depression 1.00 1.12 (0.83–1.50)
Depression changes to no depression 1.00 1.97 (1.14–3.40)*
Persistent depression symptoms 1.00 2.23 (1.09–4.57)*
ORs obtained using imputed data.
aAdjusted for age.
bAdjusted for Model 2 plus marital status to 5-year FU, changes to family annual incomes to 5-year FU, and maternal education.
cFurther adjusted for psychotropic drugs and body mass index.
*Statistically significant.
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the subsequent 14-year FU. Perhaps surprisingly, this study
also found that a positive change in depression symptoms
(depression to no depression) was significantly associated with
diabetes at 21-year FU. Women who had persistent symptoms
of depression at both 5-year FU and 14-year FU were signif-
icantly associated with diabetes at 21-year FU. A greater risk
of diabetes in people with depression symptoms has been re-
ported previously.3,6,7 However, it is important to note that we
did not observe a significant association between depression
symptoms and diabetes in our cross-sectional analysis.
Our results indicated that psychological health, as measured
by change in depression symptoms, was significantly associ-
ated with the reporting of diabetes, exerting effects indepen-
dent of previously established risk factors for diabetes such as
age, socioeconomic status, education, or obesity. These factors
did not mediate the association between depression and dia-
betes; a negative change in their depression symptoms (no
depression to depression symptoms) was not significantly as-
sociated with the adverse outcome (diabetes).
Conversely, women who experienced a positive change—
that is, from having depression symptoms to having no
symptoms—had a substantial impact on diabetes. This par-
ticular finding suggests that not only current but also previous
episodes of depression are important determinant of diabetes
onset. This finding is consistent with the previous study by
Brown et al.36 They examined an association between history
of depression and incident diabetes and found individuals with
newly diagnosed diabetes were 30%more likely to have had a
previous history of depression compared with people without
diabetes.36 We replicated the same results in our sensitivity
analysis, endorsing the accuracy of our main analysis.
The possible risk mechanisms linking depression with an
increased risk for diabetes are described elsewhere.6,7 Based
on small relative and absolute effect sizes, Hasan et al. sug-
gested that the causal direction (not association) between
these two conditions may share common causes or risk fac-
tors.6 Prior to this, Mezuk suggested exploring the common
cause or risk factor.37 One of the possible explanations for the
increased risk of diabetes when symptoms of depression are
present is chronic or recurrent stress. This would result in
intermittent or sustained increased levels of cortisol and
adrenaline in biologically vulnerable individuals.38 Campayo
et al. suggested that a metabolic syndrome in depressed pa-
tients may be the mediating mechanism with chronic stress as
a potential mediator.39 This hypothesis is further strength-
ened by the fact that antidepressant use is not associated with
a lower risk of developing diabetes;40 treating depression
without addressing underlying stress does not remove or in-
fluence the risk of developing medical conditions subsequent
to depression.37 Moreover, controversy exists about the use
of antidepressants and diabetes, with some antidepressants
linked to worsening glucose control, others linked to im-
proved control, and yet more showing mixed results.41
Stress can mediate between symptoms of depression and
diabetes by over-activating the hypothalamus-pituitary-adrenal
(HPA) axis; this results in elevated cortisol levels that can inhibit
insulin function in a variety of ways.42,43 The HPA dysregula-
tion is assumed to contribute to appetite dysregulation,44,45 or
increased appetite,46 and subsequent weight gain in stressed
individuals, and it also stimulates a craving for high glycemic
and high lipid foods.45–49 Over a long period of time, this could
predispose people to developing conditions such as diabetes
mellitus.
Limitations of the study
There are some methodology-related limitations that may
affect the generalizability of our findings. The sample was
restricted to women who had at least one child, and therefore,
the results cannot be generalized to other women, and it is
possible that the associations identified may differ for men.
Two-thirds of the original cohort provided information on de-
pression throughout the study period, but in the regression
analysis, complete data on all relevant variables was only
available for just over half of these respondents. Information
was derived from either medical records or self-reported,
possibly leading to information bias and misclassification of
depression symptoms, mental health status, and/or clinical
conditions. One of the concerns with self-report measures is
that it does not provide the exact timing of the onset of a
medical condition.5 It seems unlikely, however, that self-report
is a major bias, as previous research has reported relatively
good agreement between self-report and interviews regarding
chronic somatic diseases such as diabetes.50,51 The results
suggest that with multiple follow-ups extending over a 21-year
period, the relationship between depression and diabetes is
strong; that is, persistent depression may lead to diabetes. Since
depressive symptoms and major depression has been linked to
the development of diabetes,19,20 the possibility of comorbid
anxiety and depression symptoms increasing the risk of de-
veloping diabetes should not be ruled out.
In our study a positive response for the outcome at the 21-
year follow-up represents ‘‘incident diabetes mellitus;’’
however, it is possible that women developed diabetes during
an earlier period (for example, between the 5-year and 14-
year follow-ups); similarly, a woman could have developed
gestational diabetes during a subsequent pregnancy and be
included in the group of women who reported diabetes in the
21 years after the index pregnancy. These factors could lead
to a higher prevalence andmisclassification of the outcome as
Table 4. Unadjusted and Adjusted Odds Ratios
(95% CI) of Reporting Diabetes and Depression
Symptoms at 21-Year Follow-Up
(Cross-Sectional Analysis)
Items
No diabetes
(referent)
Diabetes
mellitus
Not depressed (referent) 1.00 1.00
Model 1 (unadjusted) n = 3663
Depression symptoms 1.00 1.44 (1.03–2.02)*
Model 2a (age-adjusted) n = 3663
Depression symptoms 1.00 1.48 (1.05–2.07)*
Model 3b (adjusted) n = 3663
Depression symptoms 1.00 1.34 (0.94–1.89)
Model 4c (adjusted) n = 3663
Depression symptoms 1.00 1.28 (0.90–1.82)
ORs obtained using imputed data.
aAdjusted for age.
bAdjusted for 2 plus marital status at 21-year FU, family income
at 21-yr, maternal education.
cFurther adjusted for body mass index at 21-year FU.
*Statistically significant.
PSYCHOLOGICAL HEALTH AND THE RISK OF DIABETES 917
well as potential bias. Therefore, we used the term associa-
tion instead of prediction to reduce bias and also to signify a
statistical relationship rather than causality.
Conclusions
Our study suggests that persistent symptoms of depression
and womenwith a positive history of depression are associated
with an elevated risk of diabetes. Despite some limitations, this
study provides insight into the long-term association between
changes in depression symptoms and diabetes across the re-
productive life of women and provides an interesting finding
that warrants further study. It also highlights that women who
are depressed in their early ages (20s–30s) possibly have an
increased risk of diabetes later in life, whether or not the de-
pression persists. These women would be worth targeting for
nutrition and other lifestyle modifications, as well as education
about symptoms of diabetes.
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